Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Comparative efficacy and tolerance of s.c. and i.m. Puregon

March 4, 1997

Sumitomo Metal reveals hypoglycemic/hypolipidemic agents

March 3, 1997

Genzyme Transgenics produces protential diabetes Rx in mouse milk

Feb. 28, 1997

Preliminary clinical data reported for OP-1

Feb. 26, 1997

Lilly claims compounds for postmenopausal syndrome

Feb. 26, 1997

Hemosol's blood substitute advances to phase II

Feb. 25, 1997

Agents for infertility described by Novo Nordisk

Feb. 25, 1997

GH-releasing peptides from Novo Nordisk

Feb. 25, 1997

Novo Nordisk's growth hormone now available in 67 countries

Feb. 24, 1997

Merck's Fosamax earns recommendation

Feb. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...